New embryo genetic test aims to cut miscarriages and birth defects

NCT ID NCT07533630

Not yet recruiting Knowledge-focused Sponsor: Reproductive & Genetic Hospital of CITIC-Xiangya Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test an upgraded genetic test (PGT-A upgrade) on embryos from 1,700 IVF patients across multiple countries. The test looks for a wider range of chromosomal issues than standard tests. Researchers hope this will help select healthier embryos, reducing the chance of miscarriage and birth defects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PGT-A upgrade genetic test
What this could lead to: If successful, this could improve embryo selection in IVF, potentially lowering miscarriage and birth defect rates.
What could go wrong: This is an observational study, not a treatment trial. It may not directly improve pregnancy outcomes, and results may take years to apply clinically.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY ASSISTED REPRODUCTIVE TECHNOLOGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFERTILITY ASSISTED REPRODUCTIVE TECHNOLOGY

Contacts and locations

Locations

Biocódices

Buenos Aires, Argentina
CITIC-Xiangya Reproductive & Genetic Hospital

Changsha, Hunan, China
First People's Hospital of Yunnan Province

Kunming, Yunnan, China
Institute Bernabéu

Alicante, Spain
Miracle

Daegu, South Korea
Nanjing Women and Children's Healthcare Hospital

Nanjing, Jiangsu, China
Thomson Hospital

Petaling Jaya, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.